Biomarkers of inflammation and progression of chronickidney disease
Top Cited Papers
- 1 July 2005
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 68 (1), 237-245
- https://doi.org/10.1111/j.1523-1755.2005.00398.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney diseaseKidney International, 2004
- Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?Atherosclerosis, 2003
- Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease StudyKidney International, 2002
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Association between renal insufficiency and malnutrition in older adults: Results from the NHANES IIIKidney International, 2001
- Reduced levels of TNFα in hypercholesterolemic individuals after treatment with pravastatin for 8 weeksAtherosclerosis, 2001
- Pravastatin experience in elderly and non-elderly patientsAtherosclerosis, 1993
- Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal ImpairmentThe Journal of Clinical Pharmacology, 1992
- Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)The American Journal of Cardiology, 1991
- Lipids and Progressive GlomerulosclerosisAmerican Journal of Nephrology, 1988